A(z) Talking Points csatorna legjobb podcastjai (2023)

H

HII Talking Points

1
Inside Ingalls | Family Day 2023 5:25

1M ago5:25

5:25

On this episode of Inside Ingalls, we answer all of your Family Day questions about the fun activities planned, the ship tour of Richard M. McCool Jr. (LPD 29), giveaways, registration and more!Huntington Ingalls Industries által

H

HII Talking Points

1
Inside Ingalls | Family Day 2023 5:24

1M ago5:24

5:24

On this episode of Inside Ingalls, get answers to the questions you have about Family Day. From how to register to what to wear and more, the fourth episode of our podcast spotlights this upcoming event.Huntington Ingalls Industries által

H

HII Talking Points

1
Inside Ingalls | Lisa Bradley 5:59

2M ago5:59

5:59

#IngallsShipbuilding takes pride in being a leader in the community. We support community organizations and events throughout the year, with a focus on causes that are close to the hearts of our shipbuilders. In this episode, Lisa Bradley, manager of corporate stewardship and community relations spotlights Ingalls Cares and the positive initiatives…

T

Talking Points

1
The FRAME-AMI Trial 9:07

2M ago9:07

9:07

Joo-Yong Hahn and C. Michael Gibson compare FFR with angiography-guided PCI for patients with acute myocardial infarction and multivessel disease.TCTMD által

T

Talking Points

1
MASTER DAPT: Long-Term Results 5:58

3M ago5:58

5:58

Marco Valgimigli and C. Michael Gibson discuss the long-term follow-up results from MASTER DAPT, which compared the outcomes of high bleeding risk patients randomized to either abbreviated or standard antiplatelet therapy.TCTMD által

T

Talking Points

1
Episode 180: The PANTHER Trial 8:19

3M ago8:19

8:19

Marco Valgimigli and C. Michael Gibson discuss the PANTHER trial, which compared P2Y12 inhibitor monotherapy with aspririn monotherapy in patients with coronary artery disease.TCTMD által

T

Talking Points

1
Radial vs. Femoral Access for PCI: Meta-Analysis 9:44

3M ago9:44

9:44

Giuseppe Gargiulo and C. Michael Gibson discuss whether the choice of radial or femoral artery access impacts the risk of mortality and major bleeding for patients undergoing coronary procedures.TCTMD által

T

Talking Points

1
Episode 181: ACT Outpatient and Inpatient Trials 5:39

4M ago5:39

5:39

Sanjit Jolly and C. Michael Gibson discuss if colchicine and rivaroxaban plus aspirin can slow disease progression in patients hospitalized with COVID-19.TCTMD által

T

Talking Points

1
Episode 180: The VALOR-HCM Trial 9:35

4M ago9:35

9:35

Milind Desai and C. Michael Gibson compare the results of mavacamten for severe obstructive hypertropic cardiomyopathy with the typical treatments of surgical septal myectomy or alcohol ablation.TCTMD által

T

Talking Points

1
Episode 179: The SODIUM-HF Study 10:57

5M ago10:57

10:57

Justin Ezekowitz and C. Michael Gibson look at a sodium-reducing dietary intervention and its effects on patients with HF.TCTMD által

T

Talking Points

1
Episode 178: The COMPLETE Trial 7:44

5M ago7:44

7:44

Shamir Mehta and C. Michael Gibson discuss how complete revascularization affects angina-related quality of life in patients with STEMI.TCTMD által

T

Talking Points

1
Episode 177: The EDIT-CMD Trial 10:45

6M ago10:45

10:45

Tijn Jansen, Suzette Elias-Smale, and C. Michael Gibson discuss whether diltiazem improves coronary vasomotor dysfunction in patients with angina and nonobstructive coronary artery disease.TCTMD által

T

Talking Points

1
Episode 176: The IVVE Trial 7:21

6M ago7:21

7:21

Mark Loeb and C. Michael Gibson discuss whether the influenza vaccine can reduce adverse vascular events among patients with HF.TCTMD által

T

Talking Points

1
Episode 175: The METEORIC-HF Trial 8:53

7M ago8:53

8:53

Gregory Lewis and C. Michael Gibson discuss how omecamtiv mecarbil affects exercise tolerance in patients with chronic HFrEF.TCTMD által

H

HII Talking Points

1
Inside Ingalls | Willie Fairley 10:40

7M ago10:40

10:40

No matter the role, the work of an Ingalls shipbuilder is both complex and inspiring. For 85 years, the world-class shipbuilders at Ingalls Shipbuilding have designed, built and maintained amphibious ships, destroyers, and cutters for the U.S. Navy and the U.S. Coast Guard. Welcome to Inside Ingalls, a podcast that dives deep into the stories and p…

T

Talking Points

1
Episode 174: The DIAMOND Trial 7:50

7M ago7:50

7:50

Javed Butler and C. Michael Gibson discuss using patiromer to manage hyperkalemia in patients with HFrEF who are taking RAAS inhibitors.TCTMD által

T

Talking Points

1
Episode 173: MAVA-LTE: The EXPLORER-LTE Cohort 8:13

8M ago8:13

8:13

Florian Rader and C. Michael Gibson look at cumulative outcomes for patients with obstructive hypertrophic cardiomyopathy treated with mavacamten.TCTMD által

T

Talking Points

1
Episode 172:The PACIFIC-AF Study 7:54

8M ago7:54

7:54

Manesh Patel and C. Michael Gibson discuss the results of a phase II trial comparing the safety profiles of asundexian versus apixaban in patients with atrial fibrillation.TCTMD által

T

Talking Points

1
Episode 171: The PROTECT Trial 7:19

8M ago7:19

7:19

Daniel Sessler and C. Michael Gibson compare myocardial injury rates following mild hypothermia versus aggressive warming during noncardiac surgery.TCTMD által

T

Talking Points

1
Episode 170: The ADAPT-TAVR Trial 14:37

9M ago14:37

14:37

Duk-Woo Park and C. Michael Gibson discuss edoxaban vs dual antiplatelet therapy for valve thrombosis and cerebral thromboembolism after TAVI.TCTMD által

T

Talking Points

1
Episode 169: The FLAVOUR Trial 16:44

9M ago16:44

16:44

Bon-Kwon Koo and C. Michael Gibson compare the efficacy of FFR-guided and IV ultrasound-guided PCI for coronary artery stenosis.TCTMD által

T

Talking Points

1
Episode 168: The GIPS-IV Study 8:09

10M ago8:09

8:09

Marie-Sophie de Koning and C. Michael Gibson discuss whether the use of sodium thiosulfate after STEMI helps preserve cardiac function.TCTMD által

T

Talking Points

1
Episode 167: The Spyral HTN-ON MED Pilot Study 5:00

10M ago5:00

5:00

Felix Mahfoud and C. Michael Gibson examine the efficacy of renal denervation for long-term BP reduction in patients taking antihypertensive medication.TCTMD által

T

Talking Points

1
Episode 166: Chronic Kidney Disease In CANTOS 7:23

11M ago7:23

7:23

Paul Ridker and C. Michael Gibson discuss a secondary analysis from CANTOS looking at residual inflammatory and cholesterol risks based on chronic kidney disease status.TCTMD által

T

Talking Points

1
Episode 165: The STAR-T/D Trial 4:21

11M ago4:21

4:21

Michael Mack and C. Michael Gibson discuss a novel method for extracting antithrombotics from the blood during CABG.TCTMD által

H

HII Talking Points

1
Ingalls Shipbuilding | Inside Ingalls: Episode 1, Kari Wilkinson 9:59

12M ago9:59

9:59

Welcome to Inside Ingalls! The first episode featuring Ingalls President Kari Wilkinson is available now. This brand-new monthly video podcast will provide an inside look at the people, community and legacy that make Ingalls Shipbuilding what it is. With more than eight decades of history, there are plenty of stories to tell. This series will featu…

T

Talking Points

1
Episode 164: The LOOP Study for AF Screening 16:31

12M ago16:31

16:31

C. Michael Gibson and Jesper Hastrup Svendsen discuss the use of implantable loop recorders to prevent stroke in AF.TCTMD által

T

Talking Points

1
Episode 163: The ENVISAGE-TAVI AF Trial 7:18

12M ago7:18

7:18

C. Michael Gibson and George Dangas discuss edoxaban vs vitamin K antagonists after TAVI in patients with atrial fibrillation.TCTMD által

T

Talking Points

1
Episode 162: The FIGARO-DKD Trial 7:30

1y ago7:30

7:30

Episode 162: The FIGARO-DKD Trial by TCTMDTCTMD által

T

Talking Points

1
Episode 161: AMULET-IDE: One-Year Outcomes 6:45

1y ago6:45

6:45

C. Michael Gibson and Dhanunjaya Lakkireddy discuss device success and thrombus risk in Amulet versus Watchman for LAA closure.TCTMD által

T

Talking Points

1
Episode 160: Shock Classification Gets an Update 4:06

1y ago4:06

4:06

C. Michael Gibson and Timothy Henry discuss key updates to the SCAI SHOCK classifications.TCTMD által

T

Talking Points and How to Argue

1
Different ideas melding. Stoic Stingray, Cunning Chameleon. 41:17

1y ago41:17

41:17

Hi Listener This episode I am joined by 2 minds I consider intelligent and respectable. This was the first time they met each other and they both really enjoyed the experience, I am grateful I get to share this with you. Stay tuned for more topics you might get interested in, and if you are starting here, welcome, and enjoy the previous podcasts. P…

T

Talking Points

1
Episode 159: MICHELLE: Rivaroxaban in COVID-19 7:37

1y ago7:37

7:37

C. Michael Gibson and Renato Lopes discuss extended DOAC prophylaxis in medically ill, hospitalized patients with COVID-19.TCTMD által

T

Talking Points and How to Argue

1
Placebo, beliefs, human focus and influence. Cunning Chameleon. 1:09:08

1y ago1:09:08

1:09:08

Hi Listener This podcast I am joined by my good friend Cunning Chameleon and together we do what we normally do, talk, discuss and bring up topics. In this episode we had a short break between and got back to it. After a long episode we lost ourselves in the conversation and at the end were reminded it was a podcast. We were a lot less filtered and…

T

Talking Points

1
Episode 158: The RIPCORD 2 Trial 10:33

1y ago10:33

10:33

C. Michael Gibson and Nicholas Curzen discuss whether routine pressure-wire assessment influences the use of coronary angiography for diagnosing chest pain.TCTMD által

T

Talking Points and How to Argue

1
Transducer? Does technology hinder our skills but improve our abilities? Lethargic Lizard Stoic Stingray 37:14

1y ago37:14

37:14

Hi Listeners, This episode introduces a new guest, Stoic Stingray, and welcome backs a previous guest under a new name, Lethargic Lizard. The podcast sound has a fan in the background that I could not remove, though as I noticed it I placed the fan further away. I really enjoyed this podcast and left it open for another continuing podcast, I can't …

T

Talking Points and How to Argue

1
Believing it makes it true if you believe it does? Cunning Chameleon 41:20

1y ago41:20

41:20

Cunning Chameleon on again, resident guest :). What we think about Belief systems and their consequences. Stay tuned for more topics you might get interested in, and if you are starting here, welcome, and enjoy the previous podcasts.CC által

T

Talking Points

1
Episode 157: PARTNER 3: Two-Year Economic Outcomes 4:33

1y ago4:33

4:33

C. Michael Gibson and David Cohen discuss cost implications of this TAVI versus SAVR randomized trial.TCTMD által

T

Talking Points and How to Argue

1
Should we pay attention and is charisma learnable? Cunning Chameleon 37:50

1y ago37:50

37:50

This episode I brave badge speak with cunning chameleon in a much more interviewed approach of interesting conversations and topics. Stay tuned for more topics you might get interested in, and if you are starting here, welcome, and enjoy the previous podcasts.CC által

T

Talking Points

1
Episode 156: The IAMI Trial 8:19

1y ago8:19

8:19

C. Michael Gibson and Ole Fröbert discuss the potential for influenza vaccination in post-MI patients.TCTMD által

T

Talking Points

1
Episode 155: Two DCBs Go Head to Head in De Novo CAD 12:14

1+ y ago12:14

12:14

C. Michael Gibson and Wan Azman Wan Ahmad discuss a sirolimus-versus a paclitaxel-coated balloon in de novo coronary lesions.TCTMD által

T

Talking Points and How to Argue

1
What will our future look like? Cunning Chameleon 32:52

1+ y ago32:52

32:52

Stay tuned for more topics you might get interested in, and if you are starting here, welcome, and enjoy the previous podcasts.CC által

T

Talking Points and How to Argue

1
What is consciousness? Likeable Leopard, Cunning Chameleon. 34:05

1+ y ago34:05

34:05

This episode I am joined by 2 people I respect, we discuss a lot of topics we believe are relevant to one another and are important things to consider instead of just blatantly believing. Stay tuned for more topics you might get interested in, and if you are starting here, welcome, and enjoy the previous podcasts.…

T

Talking Points

1
Episode 154: The EMPEROR-Preserved Trial 5:14

1+ y ago5:14

5:14

C. Michael Gibson and Stefan Anker discuss the effects of empagliflozin on CV death and HF hospitalizations in patients with HFpEF, with and without diabetes.TCTMD által

T

Talking Points and How to Argue

1
Are things structured? Cunning Chameleon 28:44

1+ y ago28:44

28:44

Hi Listeners, I am Brave Badger. Welcome to the official format of this podcast. Today I welcome a new guest Cunning Chameleon who extends his greetings to you as well. Enjoy a podcast of interesting topics and good nature conversation. Stay tuned for more topics you might get interested in, and if you are starting here, welcome, enjoy the previous…

T

Talking Points

1
Episode 153: iFR-SWEDEHEART at 5 Years 6:30

1+ y ago6:30

6:30

C. Michael Gibson and Matthias Götberg review 5-year findings after iFR- versus FFR-guided PCI.TCTMD által

T

Talking Points and How to Argue

1
Why talk about it? 16:37

1+ y ago16:37

16:37

This was a forceful start of my podcast journey, a moment of "just do it" that got the ball rolling to what it is now, I can't bring myself to remove it despite the low quality and monologue. Humble beginnings I guess. Stay tuned for more topics you might get interested in, and if you are starting here, welcome, and enjoy the previous podcasts.…

T

Talking Points

1
Episode 152: PRONOUNCE: Prostate Cancer Drugs and CVD 10:24

1+ y ago10:24

10:24

Renato Lopes and C. Michael Gibson discuss PRONOUNCE comparing the cardiovascular safety of degarelix vs. leuprolide in patients with advanced prostate cancer and CVD.TCTMD által

T

Talking Points

1
Episode 151: Stopping Amputation Post-revascularization: Novel Data in Mitigation of Thrombosis Risk 9:01

1+ y ago9:01

9:01

Desai and Anahita Dua discuss highlights from a CME program on reducing thrombosis risks in patients with PAD post-revascularization. Claim credit: https://bit.ly/3QTpBt6. Supported by an educational grant from Janssen Scientific Affairs, LLC.TCTMD által

T

Talking Points